Julius Knowles
Known title: DirectorCIK: 0001808365
Associated companies
Transaction History
| KROS | ▼ Sell | Open Market | 2,625 | $28K | 6/4/2026 | View on chart |
| KROS | ▲ Buy | Grant | 7,142 | $0 | 6/3/2026 | View on chart |
| KROS | ▼ Sell | Other | 191,527 | $3.4M | 11/21/2025 | View on chart |
| KROS | ▼ Sell | Other | 130,494 | $2.3M | 11/21/2025 | View on chart |
| KROS | ▲ Buy | Grant | 5,250 | $0 | 6/4/2025 | View on chart |
| KROS | ▼ Sell | Open Market | 419 | $24K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 271 | $16K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 1,356 | $79K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 886 | $52K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 667 | $39K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 435 | $26K | 1/5/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 524 | $29K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 794 | $44K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 2,124 | $119K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 1,383 | $78K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 1,707 | $97K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 1,113 | $63K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 4,151 | $241K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 2,704 | $157K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 3,367 | $198K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 2,195 | $129K | 1/4/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 3,412 | $201K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 249 | $15K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 162 | $10K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 5,094 | $295K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 3,678 | $209K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 2,406 | $137K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 3,318 | $192K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 5,236 | $309K | 1/3/2022 | View on chart |
| KROS | ▼ Sell | Open Market | 79 | $4K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 52 | $3K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 6,372 | $339K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 4,155 | $221K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 8,747 | $471K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 5,705 | $307K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 138 | $8K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 90 | $5K | 12/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 4,243 | $227K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,766 | $148K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 5,168 | $283K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,372 | $184K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,528 | $141K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,649 | $92K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,566 | $88K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,021 | $57K | 12/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,346 | $100K | 11/3/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,957 | $165K | 11/3/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 6,067 | $253K | 11/3/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,597 | $153K | 11/3/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,120 | $89K | 11/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 991 | $43K | 11/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,252 | $137K | 11/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,518 | $65K | 11/2/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 7,350 | $312K | 11/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 4,599 | $192K | 11/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 4,797 | $204K | 11/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 7,057 | $295K | 11/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,463 | $56K | 10/20/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 229 | $9K | 10/20/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 148 | $6K | 10/20/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,242 | $86K | 10/20/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 460 | $18K | 10/19/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 704 | $27K | 10/19/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,323 | $50K | 10/19/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,029 | $77K | 10/19/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 8,252 | $311K | 10/18/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 5,382 | $203K | 10/18/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 92 | $4K | 10/18/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 60 | $2K | 10/18/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,031 | $118K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,977 | $77K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,839 | $73K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,199 | $47K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 92 | $4K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 60 | $2K | 10/15/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,653 | $106K | 10/14/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,730 | $69K | 10/14/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,584 | $63K | 10/5/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,033 | $41K | 10/5/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,267 | $91K | 10/4/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 1,479 | $59K | 10/4/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 3,827 | $154K | 10/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 2,496 | $100K | 10/1/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 27,373 | $1.1M | 9/27/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 17,854 | $723K | 9/27/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 20,292 | $843K | 9/27/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 13,233 | $549K | 9/27/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 10,018 | $424K | 9/27/2021 | View on chart |
| KROS | ▼ Sell | Open Market | 6,532 | $276K | 9/27/2021 | View on chart |
| KROS | ▲ Buy | Open Market | 1,191 | $25K | 4/13/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Keros Therapeutics Doses First Patient in Phase 2 Rinvatercept Trial
Keros Therapeutics has announced the dosing of the first patient in a Phase 2 clinical trial evaluating rinvatercept for Duchenne Muscular Dystrophy. This milestone marks a significant step in the development of the company's lead candidate. The stock is currently trading near its support level, with analysts setting an average price target of $19.83.
Keros Therapeutics Doses First Patient in Phase 2 Rinvatercept Trial. Keros Therapeutics has announced the dosing of the first patient in a Phase 2 clinical trial evaluating rinvatercept for Duchenne Muscular Dystrophy. This milestone marks a significant step in the development of the company's lead candidate. The stock is currently trading near its support level, with analysts setting an average price target of $19.83.